Sentinel Oncology
Drug discovery company developing small-molecule cancer candidates for brain tumours, licensed to pharma and biotech partners
Highlights
- New on EvolcAdded 2026-11-17
About Sentinel Oncology
Sentinel Oncology is a drug discovery company that designs and optimises small-molecule oncology candidates. Its pipeline targets primary brain tumours and systemic tumours that frequently spread to the brain, and it takes candidates from initial concept through to clinical entry.
The company develops drug candidates for partnering with pharmaceutical and biotechnology organisations and works on a collaborative model. In September 2022 it signed an exclusive worldwide licence with PharmaEngine, Inc. for SOL578, a small-molecule Chk1 inhibitor. It also cites the licensing of its S6K1 programme.
Founded in 2005 in Cambridge, UK, the company is headquartered in Cambridge. It reports three late-stage preclinical programmes and announced the first dose in a phase 1 cancer trial of SOL578 in August 2023.
Product: Development and licensing of targeted small-molecule oncology drug candidates, mainly for primary and metastatic brain tumours.
Jobs at Sentinel Oncology
Leadership
- Robert G Boyle · Founder & CEOSource: company website
- Stuart Travers · Founder & COOSource: company website
More biotech & pharma companies
Sequoia Genetics
Human genetics research and analysis for pharma, biotech, investors, and academic institutions developing medicinesYoung companyNew on EvolcSerac Healthcare
Develops molecular imaging agents for clinicians treating endometriosis, interstitial lung disease and inflammatory arthritisNew on EvolcSeren Plus
Wholesale supplier of prescription medicines and aesthetic products to pharmacies and clinics across the UKShafi Consultancy
Clinical trial statistical programming and data services for pharmaceutical companies and contract research organizationsNew on EvolcSiinovia (UK)
Develops and distributes niche generic and value-added medicines for healthcare markets and pharmaceutical partnersNew on EvolcSimplex Molecular
Molecular biology R&D, assay development and testing for research teams and businessesYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.